Vimarsana
Biggest News Aggregation in the World

Benjamin Slavin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Slavin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Slavin Today - Breaking & Trending Today

This bond ETF will deliver a big return in 2024: VettaFi's Rosenbluth - Vimarsana News

This bond ETF will deliver a big return in 2024: VettaFi's Rosenbluth

Longer-term Treasurys like the iShares 20-year Treasury ETF could payoff for investors this year if the Fed cuts rates more than expected.

Source: cnbc.com
Así protege la vacuna de la gripe contra la Covid-19 - Vimarsana News

Así protege la vacuna de la gripe contra la Covid-19

Hace meses que investigadores de todo el mundo desarrollan estudios sobre la capacidad de protección de...

Así protege la vacuna de la gripe contra el coronavirus - Vimarsana News

Así protege la vacuna de la gripe contra el coronavirus

Hace meses que investigadores de todo el mundo desarrollan estudios sobre la capacidad de protección de la vacuna de la gripe frente a la Covid-19. Al...

Vacunarse de la gripe reduce la probabilidad de ingresar en UCI por Covid-19, dice estudio - Vimarsana News

Vacunarse de la gripe reduce la probabilidad de ingresar en UCI por Covid-19, dice estudio

Los resultados, según los autores del estudio, sugieren firmemente que la vacuna antigripal puede proteger contra varios efectos graves del Covid-19

Flu vaccine may provide vital protection against COVID-19, study shows - Vimarsana News

Flu vaccine may provide vital protection against COVID-19, study shows

Flu vaccine may provide vital protection against COVID-19, study shows In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19. The study, titled "Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients," was published in the peer-reviewed scientific journal PLoS One on August 3. This was the largest study of its kind and analyzed deidentified patient records from around the world, which strongly s...